06.17.2009 6:21 pm
Mallinckrodt in licensing deal for Exalgo
St. Louis Post-Dispatch
Covidien’s Mallinckrodt Inc. unit based in Hazelwood has acquired the licensing rights to Exalgo, an extended release formulation of hydromorphone, from a unit of Neuromed Pharmaceuticals Ltd.
Exalgo, an opioid analgesic, is awaiting Food and Drug Administration approval. Financial terms of the deal…
- Comments Off
- Email this
